Inside Biotech
Avsnitt

The Future of Mental Health Treatment with Shawn Singh, CEO of Vistagen

Inside Biotech
Dela

CEO of Vistagen, Shawn Singh, returns to Inside Biotech to discuss groundbreaking developments in intranasal therapeutics. Shawn shares exciting results from Vistagen’s fast-track phase 3 trials, explains how intranasal drug delivery bypasses limitations of traditional therapeutics relying on systemic absorption, and reflects on telehealth’s role in accessibility. This conversation spotlights a transformative moment in neuroscience, drug development and mental health innovation.

Learn more about Vistagen: https://www.vistagen.com/
Listen to our previous episode with Shawn to learn more about social anxiety disorder and the earlier days of Vistagen: https://inside-biotech.simplecast.com/episodes/shawn-singh-ceo-of-vistagen-mental-health-biopharmaceuticals

Follow our Instagram @insidebiotech for updates about episodes and upcoming guests!

To learn more about BCLA’s events and consulting visit our website.

Follow BCLA on LinkedIn

 

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Daniel Arce, Bryan Jimenez, Danielle Luu, Stephanie Wu, Riley Elmer, Sanju Vardhan, Karishma Chhugani, Ethan Chung. Innehållet i podden är skapat av Daniel Arce, Bryan Jimenez, Danielle Luu, Stephanie Wu, Riley Elmer, Sanju Vardhan, Karishma Chhugani, Ethan Chung och inte av, eller tillsammans med, Poddtoppen.